Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Vaccine ; 25(51): 8562-73, 2007 Dec 12.
Article in English | MEDLINE | ID: mdl-18036708

ABSTRACT

Smallpox vaccination with replication deficient vaccinia strains such as Modified Vaccinia Ankara (MVA) may induce protective immunity with improved safety and tolerability profiles compared with currently available smallpox vaccines. Ninety subjects were randomized equally to six groups in a partially blinded, randomized, controlled clinical trial. IMVAMUNE (MVA-BN, Bavarian Nordic A/S, Kvistgård, Denmark) vaccine or placebo was administered at Study Days 0 and 28 by subcutaneous or intramuscular injection and five groups were challenged with Dryvax at study Day 112. Vaccination with two doses of IMVAMUNE was safe and well tolerated compared to Dryvax. IMVAMUNE produced comparable cellular and humoral immune responses to one dose of Dryvax and the immunity induced appears robust 90 days post-vaccination by evidence of attenuated primary cutaneous reaction responses following Dryvax. IMVAMUNE vaccination prior to Dryvax reduced virus replication at the Dryvax site, decreased the size of the primary cutaneous lesion, and decreased the time to healing but did not completely ameliorate the immune response.


Subject(s)
Smallpox Vaccine/immunology , Vaccines, Attenuated/immunology , Vaccinia virus/immunology , Adolescent , Adult , Chemistry, Pharmaceutical , Enzyme-Linked Immunosorbent Assay , Erythema/immunology , Female , Heart Diseases/genetics , Humans , Immunoglobulin G/biosynthesis , Immunoglobulin G/immunology , Interferon-gamma/biosynthesis , Interferon-gamma/genetics , Male , Skin/pathology , Smallpox Vaccine/adverse effects , T-Lymphocytes/immunology , Vaccines, Attenuated/adverse effects , Viral Plaque Assay
2.
J Virol ; 78(22): 12395-405, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15507626

ABSTRACT

In this report we questioned the current view that the two principal cytotoxic pathways, the exocytosis and the Fas ligand (FasL)/Fas-mediated pathway, have largely nonoverlapping biological roles. For this purpose we have analyzed the response of mice that lack Fas as well as granzyme A (gzmA) and gzmB (FasxgzmAxB(-/-)) to infection with lymphocytic choriomeningitis virus (LCMV). We show that FasxgzmAxB(-/-) mice, in contrast to B6, Fas(-/-), and gzmAxB(-/-) mice, do not recover from a primary infection with LCMV, in spite of the expression of comparable numbers of LCMV-immune and gamma interferon-producing cytotoxic T lymphocytes (CTL) in all mouse strains tested. Ex vivo-derived FasxgzmAxB(-/-) CTL lacked nucleolytic activity and expressed reduced cytolytic activity compared to B6 and Fas(-/-) CTL. Furthermore, virus-immune CTL with functional FasL and perforin (gzmAxB(-/-)) are more potent in causing target cell apoptosis in vitro than those expressing FasL alone (perfxgzmAxB(-/-)). This synergistic effect of perforin on Fas-mediated nucleolysis of target cells is indicated by the fact that, compared to perfxgzmAxB(-/-) CTL, gzmAxB(-/-) CTL induced (i) an accelerated decrease in mitochondrial transmembrane potential, (ii) increased generation of reactive oxygen species, and (iii) accelerated phosphatidylserine exposure on plasma membranes. We conclude that perforin does not mediate recovery from LCMV by itself but plays a vital role in both gzmA/B and FasL/Fas-mediated CTL activities, including apoptosis and control of viral infections.


Subject(s)
Apoptosis , Lymphocytic Choriomeningitis/immunology , Membrane Glycoproteins/physiology , fas Receptor/physiology , Animals , Antigens, Differentiation/physiology , Endopeptidases/physiology , Fas Ligand Protein , Granzymes , Lymphocytic Choriomeningitis/metabolism , Lymphocytic Choriomeningitis/pathology , Mice , Mice, Inbred BALB C , Perforin , Pore Forming Cytotoxic Proteins , Reactive Oxygen Species/metabolism , Serine Endopeptidases/physiology , T-Lymphocytes, Cytotoxic/immunology
3.
Eur J Immunol ; 34(10): 2681-9, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15368284

ABSTRACT

The expression of housekeeping and/or immunoproteasomes in isolated thymic stroma subsets has so far not been analyzed but may have important consequences for self peptide repertoires presented by MHC class I molecules during positive and negative thymic selection. Here we determined the expression of housekeeping and immunoproteasome beta subunits and of PA28 in positively and negatively selecting stroma subsets. Positively selecting cortical thymic epithelial cells (cTEC) expressed only housekeeping but no immunoproteasome beta subunit mRNA and proteins. However, immunoproteasome beta subunits could be induced in cTEC by infection with Listeria monocytogenes or injection of IFN-gamma. In negatively selecting stroma including medullary epithelial cells and dendritic cells, incomplete and low representation of housekeeping beta subunit proteins but high and complete expression of immunoproteasome beta subunit proteins suggests absence of proper housekeeping proteasomes and predominance of immunoproteasomes. Expression of immunoproteasome beta subunits in negatively selecting stroma was independent of IFN-gamma receptor as shown in knockout (KO) mice. Absence of LMP2 altered thymic selection of the MHC class I-restricted transgenic P14 TCR in KO mice. The data suggest that negative selection may primarily involve immunoproteasome peptide repertoires and that peripheral infection may influence peptide repertoires involved in positive selection.


Subject(s)
Gene Expression Regulation/immunology , Proteasome Endopeptidase Complex/immunology , T-Lymphocytes/immunology , Thymus Gland/cytology , Thymus Gland/immunology , Animals , Blotting, Western , Electrophoresis, Polyacrylamide Gel , Flow Cytometry , Interferon-gamma/immunology , Mice , Mice, Knockout , Muscle Proteins/genetics , Muscle Proteins/immunology , Proteasome Endopeptidase Complex/genetics , Protein Subunits/genetics , Protein Subunits/immunology , Reverse Transcriptase Polymerase Chain Reaction
4.
Arthritis Res Ther ; 6(5): R433-46, 2004.
Article in English | MEDLINE | ID: mdl-15380043

ABSTRACT

The pathogenesis of chronic inflammatory joint diseases such as adult and juvenile rheumatoid arthritis and Lyme arthritis is still poorly understood. Central to the various hypotheses in this respect is the notable involvement of T and B cells. Here we develop the premise that the nominal antigen-independent, polyclonal activation of preactivated T cells via Toll-like receptor (TLR)-2 has a pivotal role in the initiation and perpetuation of pathogen-induced chronic inflammatory joint disease. We support this with the following evidence. Both naive and effector T cells express TLR-2. A prototypic lipoprotein, Lip-OspA, from the etiological agent of Lyme disease, namely Borrelia burgdorferi, but not its delipidated form or lipopolysaccharide, was able to provide direct antigen-nonspecific co-stimulatory signals to both antigen-sensitized naive T cells and cytotoxic T lymphocyte (CTL) lines via TLR-2. Lip-OspA induced the proliferation and interferon (IFN)-gamma secretion of purified, anti-CD3-sensitized, naive T cells from C57BL/6 mice but not from TLR-2-deficient mice. Induction of proliferation and IFN-gamma secretion of CTL lines by Lip-OspA was independent of T cell receptor (TCR) engagement but was considerably enhanced after suboptimal TCR activation and was inhibitable by monoclonal antibodies against TLR-2.


Subject(s)
Arthritis, Rheumatoid/metabolism , Lymphocyte Activation/physiology , Membrane Glycoproteins/physiology , Receptors, Cell Surface/physiology , T-Lymphocytes/physiology , Animals , Antigens, Surface/immunology , Arthritis, Rheumatoid/pathology , Bacterial Outer Membrane Proteins/immunology , Bacterial Vaccines , CD8-Positive T-Lymphocytes/metabolism , CD8-Positive T-Lymphocytes/physiology , Cell Line , Cell Proliferation , Female , Inflammation/metabolism , Inflammation/pathology , Interferon-gamma/metabolism , Lipoproteins/immunology , Lymphocyte Culture Test, Mixed/methods , Male , Membrane Glycoproteins/biosynthesis , Membrane Glycoproteins/deficiency , Mice , Mice, Inbred C57BL , Mice, Inbred Strains , Receptors, Cell Surface/biosynthesis , Receptors, Cell Surface/deficiency , Recombinant Proteins/immunology , T-Lymphocyte Subsets/metabolism , T-Lymphocyte Subsets/physiology , T-Lymphocytes/metabolism , T-Lymphocytes, Cytotoxic/metabolism , T-Lymphocytes, Cytotoxic/physiology , Toll-Like Receptor 2 , Toll-Like Receptors
5.
Eur J Immunol ; 33(1): 70-8, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12594834

ABSTRACT

CTL and NK cells are critical for resistance to acute Trypanosoma cruzi infection, but are also implicated in the pathology induced by this intracellular protozoan parasite. Here we explore to what extent the two main cytolytic pathways of CTL and NK cells, i.e. the granule exocytosis and the Fas ligand (FasL)/Fas pathways, are responsible for the elimination of parasites from mouse tissues and control of organ pathology. For this purpose we have employed mouse strains with targeted gene defects in one or more components - including perforin, granzyme A and granzyme B, and Fas - of either of the two cytolytic pathways, and we used the highly pathogenic T. cruzi strain Tulahuen. We show that parasites are effectively cleared from infected tissues independently of the FasL/Fas pathway by the concerted action of perforin and the two granzymes. However, prevention of pathology and early host death is critically dependent in addition on an operational FasL/Fas interaction. Thus, in contrast to C57BL/6 (B6) wild-type mice, mouse strains with deficiencies in either the FasL/Fas or the perforin/granzyme pathway similarly suffer from early death, independently of their differential capacity to control parasite growth; this finding indicates that the two cytolytic pathways control distinct but vital processes during infection with T. cruzi.


Subject(s)
Membrane Glycoproteins/metabolism , Serine Endopeptidases/metabolism , Trypanosoma cruzi/immunology , Trypanosomiasis/immunology , Trypanosomiasis/metabolism , fas Receptor/metabolism , Animals , Fas Ligand Protein , Flow Cytometry , Liver/pathology , Mice , Mice, Inbred C57BL , Myocardium/pathology , Perforin , Pore Forming Cytotoxic Proteins , Spleen/pathology , Trypanosomiasis/enzymology , Tumor Necrosis Factor-alpha/metabolism
6.
Oncogene ; 21(46): 6983-91, 2002 Oct 10.
Article in English | MEDLINE | ID: mdl-12370820

ABSTRACT

Genetic analysis of beta-catenin-induced oncogenic transformation in chicken embryo fibroblasts (CEF) revealed the following prerequisites for oncogenicity: (1) removal of the N terminal phosphorylation sites targeted by glycogen synthase kinase 3beta (GSK3beta), (2) retention of the N terminal transactivation domain, and (3) retention of the armadillo repeats. The C terminal transactivation domain played an ancillary role in the transformation of CEF. There was a rough correlation between the transforming activity of various beta-catenin constructs and their transactivation of the TOPFLASH reporter. Expression levels of the candidate target genes of beta-catenin-LEF, cyclin D1 and myc were not correlated with each other or with the transforming activity of beta-catenin constructs. A new target gene, coding for inositol hexakisphosphate kinase 2 (IP6K2) was identified. Its expression showed concordance with the transforming activity of beta-catenin constructs.


Subject(s)
Calcium-Calmodulin-Dependent Protein Kinases/genetics , Cell Transformation, Neoplastic , Cytoskeletal Proteins/physiology , Trans-Activators/physiology , Animals , Cells, Cultured , Chick Embryo , Cyclin D , Cyclins/genetics , Cytoskeletal Proteins/chemistry , Cytoskeletal Proteins/genetics , DNA-Binding Proteins/physiology , Gene Expression Regulation , Genes, myc , Glycogen Synthase Kinase 3 , Glycogen Synthase Kinases , Lymphoid Enhancer-Binding Factor 1 , Trans-Activators/chemistry , Trans-Activators/genetics , Transcription Factors/physiology , Transcriptional Activation , beta Catenin
7.
Eur J Immunol ; 32(9): 2490-9, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12207333

ABSTRACT

Activation of resting T cells usually leads to their proliferation and differentiation into effector cells and a subsequent decline following elimination of the antigen. A situation of excessive antigen density may result in T cell receptor (TCR)-induced deletion of T effector cells, a process termed antigen-induced cell death (AgICD). Previous studies indicate that AgICD of cytotoxic T cells may be induced by either of the two key cytotoxic processes, granule exocytosis, including perforin and granzymes, or the Fas ligand (FasL)/Fas pathway. By using in vitro-polyclonally activated or ex vivo-derived virus-induced T cell populations from mice with mutations or targeted gene defects in one or more components of the two key cytolytic pathways we now show that TCR-induced apoptosis is only impaired in the absence of FasL and/or Fas, but not in the absence of perforin and/or granzymes. Furthermore, antibody-blockage of FasL alone is sufficient to inhibit early T cell death. Inhibition of both, FasL and tumor necrosis factor (TNF-alpha) is required to abrogate late apoptosis by AgICD. The fact that antibodies to IFN-gamma also inhibit AgICD suggests that the perforin plus granzyme-independent and FaSL and/or TNF-alpha facilitated process of AgICD of T effector cells is tightly regulated by endogenous IFN-gamma.


Subject(s)
Antigens/immunology , Apoptosis/physiology , Interferon-gamma/physiology , Membrane Glycoproteins/physiology , T-Lymphocyte Subsets/cytology , fas Receptor/physiology , Animals , Antibodies, Monoclonal/pharmacology , Antigens, Viral/immunology , CD3 Complex/immunology , Concanavalin A/pharmacology , Exocytosis , Fas Ligand Protein , Granzymes , Lymphocyte Activation/drug effects , Lymphocytic Choriomeningitis/immunology , Lymphocytic choriomeningitis virus/immunology , Male , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Perforin , Pore Forming Cytotoxic Proteins , Serine Endopeptidases/physiology , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Tumor Necrosis Factor-alpha/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...